Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antioxidant Supplementation in Endometriotic Women Undergoing ICSI
NCT02058212Phase 2Completed
- Sponsor
- Cairo University
- Start
- Mar 2013
- Primary completion
- Oct 2013
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial (2 arms), sponsored by Cairo University. Primary endpoint: Plasma Reactive Oxygen Species Levels at 3 months. Started Mar 2013; status: completed.
Beyond the preview
Go deeper on NCT02058212.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02058212.